This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Click here for Sutent® (sunitinib malate) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.

HCP Resources

Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Dosing card (mRCC)

Dosing card for SUTENT

Dosing card for SUTENT for the treatment of advanced/metastatic renal cell carcinoma (mRCC), in order to educate clinicians on appropriate dosing of SUTENT and potential interactions 

Download to browse content Order

Therapy Management Guide (mRCC)

Guide to optimising outcomes with SUTENT

Guide to optimising outcomes with SUTENT (sunitinib malate) A guide to managing a selection of common adverse events.

Download to browse content Order

References
  1. ​​​​​​​SUTENT Summary of Product Characteristics
PP-SUT-GBR-0670. March 2021

Resources

Indication

  • SUTENT (sunitinib malate) is indicated for the treatment of advanced and/or metastatic renal cell carcinoma (mRCC) in adults.

Register to receive tailored marketing information from Pfizer by email

Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.

PP-PFE-GBR-2809. March 2021

Sign up now

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No